Heart Ultrasound Strain Testing in People With Psoriatic Arthritis
Checks for early right heart pumping problems in adults with psoriatic arthritis.
Plain-language title generated from the registry record
Registry title: Right Ventricular Strain in Detecting Subclinical Right Ventricular Systolic Dysfunction in Psoriatic Arthritis Patients: Relation to Serum Endostatin Level
Key facts
- Where
- Cairo, EgyptSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 50 years old?
Source: NCT07046312, who can take part
Where in Egypt
- Ain Shams UniversityCairo, EgyptNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Ain Shams University
- Trial code
- NCT07046312
- Record updated
- 1 July 2025
- Original description
The aim is to assess early right ventricular systolic dysfunction in psoriatic arthritis patients using RV strain echocardiographyRead full original descriptionShow less
Right Ventricular Strain in Detecting Subclinical Right Ventricular Systolic Dysfunction in Psoriatic Arthritis Patients: Relation to Serum Endostatin Level
The aim is to assess early right ventricular systolic dysfunction in psoriatic arthritis patients using RV strain echocardiography
Inclusion: Psoriatic arthritis patients according to CASPAR criteria; Psoriatic arthritis patients without overt cardiovascular symptoms; Patients with age between 20 to 50 years of age.
Exclusion: Patients taking certain drugs that have been confirmed to be risk factors for PAH such as appetite suppressant intake drugs (aminorex, fenfluramine derivatives and benfluorex) and chemotherapeutic agents; Other systemic autoimmune diseases; Patients with a history of known valvular disease, atrial fibrillation or any other arrhythmia , heart failure, ischemic cardiomyopathy severe obstructive pulmonary diseases and metabolic syndrome; Patients with medical disorders as renal, congenital heart diseases, hematological disorders and cancer patients; Family history of myocardial infarction, cerebrovascular disease or sudden death before the age of 65y in females and 55 y in males.